Lilly’s new weight loss drug retatrutide showing promising results in phase 2 study (www.indystar.com)
Eli Lilly's new weight loss drug retatrutide showed promising results for weight loss in those who took the drug for about a year.
![](https://media.kbin.social/media/cache/resolve/entry_thumb/3b/54/3b541ab14389c860c03859c5f0947b09dccd2ad55fe7d702f5a76701ea5001fd.jpg)
Eli Lilly's new weight loss drug retatrutide showed promising results for weight loss in those who took the drug for about a year.
Clinical trial participants taking retatrutide for obesity experienced an average of 24% in body weight reduction over 48 weeks. Lead scientists shared their findings at the ADA’s 83rd Scientific Sessions in San Diego.